Ventricular Tachycardia Ablation Remains Treatment of Last Resort in Structural Heart Disease: Argument for Earlier Intervention (scientific article published on 03 May 2011)

Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial

Q34069413

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

Q34386004

Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia.

Q37687517

Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.

Q38409971

Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2).

Q39641967

Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial

Q40483511

Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients.

Q43149303

Ablation of electrograms with an isolated, delayed component as treatment of unmappable monomorphic ventricular tachycardias in patients with structural heart disease

Q44347580

Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial

Q44406432

Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator

Q44974110

Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks.

Q51960027

Sudden death in the Framingham Heart Study. Differences in incidence and risk factors by sex and coronary disease status.

Q54545958

Endocardial and Epicardial Ablation Guided by Nonsurgical Transthoracic Epicardial Mapping to Treat Recurrent Ventricular Tachycardia

Q58757802

Electroanatomic Substrate and Ablation Outcome for Suspected Epicardial Ventricular Tachycardia in Left Ventricular Nonischemic Cardiomyopathy

Q58814987

Site-specific twelve-lead ECG features to identify an epicardial origin for left ventricular tachycardia in the absence of myocardial infarction

Q58815070

P433

issue

P921

main subject

ventricular tachycardia

Q56002

P304

page(s)

1123-1128

P577

publication date

2011-05-03

P1433

published in

Journal of Cardiovascular Electrophysiology

Q4736917

P1476

title

Ventricular tachycardia ablation remains treatment of last resort in structural heart disease: argument for earlier intervention

P478

volume

Reverse relations

cites work (P2860)

Q28087002	2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of [...]
Q27006486	Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review
Q28075730	Electrical Storm: Incidence, Prognosis and Therapy
Q97422279	Electrophysiology's Identity Crisis: What our Clinical Trials Do and Do Not Say About Us
Q38719314	Long-term Outcomes of Ventricular Tachycardia Ablation in Different Types of Structural Heart Disease
Q53595012	Long-term benefit of first-line peri-implantable cardioverter-defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients.
Q92740873	Management of monomorphic ventricular tachycardia electrical storm in structural heart disease
Q97548584	Optimal Timing of VT Ablation for Patients with ICD Therapies
Q52572005	Prophylactic catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials.
Q64890355	Rationale and design of BERLIN VT study: a multicenter randomised trial comparing preventive versus deferred ablation of ventricular tachycardia.
Q39401015	Role of catheter ablation of ventricular tachycardia associated with structural heart disease
Q38694901	Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials.
Q64074190	Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator
Q60922071	Team Management of the Ventricular Tachycardia Patient
Q45788785	VT ablation in heart failure
Q38187022	VT ablation: New Developments and Approaches
Q38719285	Ventricular Tachycardia Ablation - The Right Approach for the Right Patient
Q26865788	Ventricular tachycardia ablation and substrate modification in ICD patients with electrical storm
Q36232387	Ventricular tachycardia in ischemic cardiomyopathy; a combined endo-epicardial ablation as the first procedure versus a stepwise approach (EPILOGUE) - study protocol for a randomized controlled trial
Q27006725	Venturing into ventricular arrhythmia storm: a systematic review and meta-analysis
Q88019540	[Catheter ablation for the treatment of electrical storm: methods and outcome]
Q87861413	[Catheter ablation of electrical storm: ready for prime time?]
Q88019537	[Electrical storm in the emergency room: clinical pathways]

P356	DOI	10.1111/J.1540-8167.2011.02081.X
P698	PubMed publication ID	21539642